| Grau, Michael (Kuros 202209 CFO before Proteros + Correvio + Ingenium + MorphoSys) |
Chief Financial Officer (CFO) |
Kuros (Group) |
Zürich (region) |
| Haas, Franz-Werner (LimmaTech Biologics 202307– CEO before CureVac + Sygnis Pharma + Lion BIoscience + Sirona Dental) |
Chief Executive Officer (CEO) |
LimmaTech Biologics AG |
Zürich (region) |
| Hecht, Thomas (Delenex 201105 Board Chairman + Affimed 201112 Board Chairman) |
Board member, non-executive |
Athenex (Group) |
Zürich (region) |
| Kuner, Michael (Nycomed 200802– Executive VP) |
Legal Manager |
Takeda (Group) |
Zürich (region) |
| Plückthun, Andreas (Univ Zurich 200605) |
Board member, non-executive |
University of Zurich (UZH) |
Zürich (region) |
| Schnell, Beate (InSphero 201601– Head of Sales before Promega + Abbott Diagnostics) |
Sales Manager / Marketing Manager |
InSphero (Group) |
Zürich (region) |
| Traeger, Stefan (Tecan 201307–201706 Head of Life Sciences before Leica Microsystems + Zeiss LEAVES 2017) |
Board member, executive |
Tecan (Group) |
Zürich (region) |
| Llewellyn-Davies, Peter (Apeiron 201807– CEO before CFO+CBO before Accellerate Partners + Medigene + Wilex) |
Chief Executive Officer (CEO) |
Apeiron (Group) |
Wien (state) |
| Higham, Paul G. (Valo Therapeutics 202008– CEO before Glycotope + Immatics + Ark Therapeutics + GlaxoWellcome) |
Chief Executive Officer (CEO) |
Valo Therapeutics (Valo Tx) (Group) |
Uusimaa |
| Pejowski, David (Adoram Therapeutics 202210 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
|
Switzerland_other |
| Wilhelmsson, Claes |
Investment Manager |
Investor AB (Wallenberg) (Group) |
Sweden_o |
| Senne, Wolfgang (Oridis Biomarkers 201107 CEO LEFT BEFORE 5/12 before CFO before GeneScan + Carl Zeiss Medical) |
Chief Executive Officer (CEO) |
Oridis Biomarkers GmbH |
Steiermark (Styria) |
| Gaillard, Pieter J. (to-BBB 200902– CSO before CEO) |
Chief Executive Officer (CEO) |
2-BBB Medicines (Group) |
South Holland (province, NL) |
| Zech, Birgit (Anavo Therapeutics 202104 CEO before Gotham Therapeutics + X-Rx + MAB Discovery + Pieris + Axxima) |
Chief Executive Officer (CEO) |
Anavo Therapeutics (Group) |
South Holland (province, NL) |
| Mathias, Frank (Oxford Biomedica 202203– CEO before Rentschler + Medigene + Amgen GmbH + Servier DE + Hoechst) |
Managing Director |
Oxford Biomedica (Group) |
South East England (region) |
| Lensky, Stephan (EpimAb Biotherapeutics 201610 COO/CBO) |
Chief Operating Officer (COO) |
EpimAb Biotherapeutics (Group) |
Shanghai (province) |
| Schenkendorf, René (Harz Univ 202109 Professor for Manufacturing/Industry 4.0 before TU Braunschweig) |
Professor |
Harz University of Applied Sciences Wernigerode |
Sachsen-Anhalt (federal state) |
| Schäffer, Michael (Probiodrug 201810– CBO joined 201808 as EVP Business + Strategy before Crelux + Sireen) |
Business Development Manager / Strategy Manager |
Vivoryon (Group) |
Sachsen-Anhalt (federal state) |
| Stangier, Kerstin (Azenta Life Sciences Leipzig 202205 Senior Director formerly GATC Biotech 201107 Director BusDev) |
Business Development Manager / Strategy Manager |
Azenta (Group) |
Sachsen (federal state) |
| Hackenberger, Alfred (BASF 1981–) |
n. a. |
BASF (Group) |
Rheinland-Pfalz (federal state) |
| Holstein, Jens (BioNTech 202107– CFO before MorphoSys 201105–202012 CFO before Fresenius Kabi) |
Chief Financial Officer (CFO) |
BioNTech (Group) |
Rheinland-Pfalz (federal state) |
| Kalkbrenner, Frank (Boehringer 201308 CVP + Head of BIVF + CEO Acousia Therapeutics GmbH) |
Investment Manager |
Boehringer Ingelheim (Group) |
Rheinland-Pfalz (federal state) |
| Pötting, Sierk (BioNTech 202107– COO joined 201409 as CFO before Sandoz Inc/Novartis + McKinsey) |
Chief Operating Officer (COO) |
BioNTech (Group) |
Rheinland-Pfalz (federal state) |
| Vogt, Joachim (AbbvVie 201809– Director Search + Evaluation Intl before Roche + eADMET + Wilex) |
Business Development Manager / Strategy Manager |
AbbVie (Group) |
Rheinland-Pfalz (federal state) |
| Heeger, Steffen (Selvita 201802– CMO before MorphoSys 201312– Head of Clinical Research before Merck Serono) |
Chief Medical Officer (CMO) |
Selvita (Group) |
Poland_o |
| Benedict, Nicholas (Vaderis Therapeutics 202208 CEO + Co-Foudner formerly Allecra Therapeutics) |
Chief Executive Officer (CEO) |
Vaderis Therapeutics AG |
Northwestern Switzerland (region) |
| Enzelberger, Markus (Versant Ventures 202003– EIR in Basel before MorphoSys 2002–202002) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Versant Ventures |
Northwestern Switzerland (region) |
| Matentzoglu, Konstantin (Celonic 201711 CEO before Trenzyme GmbH 201202 Managing Director) |
Managing Director |
Celonic (Group) |
Northwestern Switzerland (region) |
| Smith, Andrew (Santhera 202004– CFO before Allecra Therapeutics + Sucampo Pharmaceuticals) |
Chief Financial Officer (CFO) |
Santhera (Group) |
Northwestern Switzerland (region) |
| Ballesteros, Kathrin (NLC Ventures 202111 Venture Partner formerly KBK Concept 201310) |
Partner (venture partner) |
NLC Ventures (Group) |
North Holland (province, NL) |
| Faulstich, Konrad (201011 Director Strategic Alliances before ESE GmbH 200909 Head BusDev) |
Business Development Manager / Strategy Manager |
Qiagen (Group) |
Nordrhein-Westfalen (federal state) |
| Huber, Robert (Univ Duisburg-Essen 201004 Professor ZMB before Max Planck Institute for Biochemistry, Nobel Laureate) |
Professor |
University of Duisburg-Essen |
Nordrhein-Westfalen (federal state) |
| Lehrke, Ingo (Algiax Pharmaceuticals 2019– CEO + Tubulis 202007 CBO) |
Chief Executive Officer (CEO) |
Algiax Pharmaceuticals GmbH |
Nordrhein-Westfalen (federal state) |
| Martin, Alex (Affectis 201003–CEO before CFO before Intercept before BioXell 200606 CFO before Novartis) |
Chief Executive Officer (CEO) |
Affectis Pharmaceuticals AG |
Nordrhein-Westfalen (federal state) |
| Murray, Stephen (Affectis 201105– CMO befrore Memory Pharmaceuticals before Pfizer Pharmaceuticals) |
Chief Medical Officer (CMO) |
Affectis Pharmaceuticals AG |
Nordrhein-Westfalen (federal state) |
| Nüsslein-Vollhard, Christiane |
n. a. |
Taconic (Group) |
Nordrhein-Westfalen (federal state) |
| Plum, Achim (InfanDx 202102– CEO before SphingoTec + Curetis/OpGen + Siemens + Epigenomics) |
Chief Commercial Officer (CCO) |
InfanDx (Group) |
Nordrhein-Westfalen (federal state) |
| Schaffer, Thomas (Biofrontera 201306– CFO before Siemens et al) |
Chief Financial Officer (CFO) |
Biofrontera (Group) |
Nordrhein-Westfalen (federal state) |
| Thews, Anne (SilverSky LifeSciences 201710– Principal Consultant before Curetis + Philips + Beckman Coulter) |
Consultant (economic/technology) |
SilverSky (Group) (Silversky Lifesciences) |
Nordrhein-Westfalen (federal state) |
| Vollmer, Jörg (Abalos Therapeutics 201910– CSO before Rigontec + Nexigen) |
Managing Director |
Abalos Therapeutics GmbH |
Nordrhein-Westfalen (federal state) |
| von Rüden, Thomas (Direvo Biotech –201004 CEO STEPPED DOWN 4/19 before MorphoSys) |
Chief Executive Officer (CEO) |
Bayer (Group) |
Nordrhein-Westfalen (federal state) |
| Weller, Ulrich (Labor Boogen Köln 200909 Head Microbiology) |
Laboratory Manager (industry) |
Praxis für Laboratoriumsmedizin, Hämostaseologie Dr. med. Christiane Boogen (Labor Boogen Köln) |
Nordrhein-Westfalen (federal state) |
| Müller, Gerhard Anton (Univ Göttingen 201004 Professor Faculty of Medicine + 4/10 existent Advisory Board PANATecs) |
Professor |
University of Göttingen (Georg August University) |
Niedersachsen (federal state) |
| Neermann, Jörg (Curexsys 202105– CEO before Life Sciences Partners Munich+ DVC + Atlas Venture) |
Chief Executive Officer (CEO) |
Curexsys GmbH |
Niedersachsen (federal state) |
| Steiner, Martin (ImVisioN 200505– CEO before Apovia + Evax before SKB) |
Chief Executive Officer (CEO) |
Nextech Venture L.P. |
Niedersachsen (federal state) |
| Beck, Matthew L. S. (Matt) (Hookipa 202210 Investor Relations before CureVac + Solebury Trout) |
Public Relations Manager / Investor Relations Manager |
Hookipa (Group) |
New York (federal state) |
| Tuschl, Thomas (Rockefeller Univ 200601) |
Professor |
Rockefeller Universtiy, Tuschl Lab Laboratory of RNA Molecular Biology |
New York (federal state) |
| Golumbeski, George (Celgene 201804 EVP + Executive Advisor for Innovation + proposed to MorphoSys Supervisory Board) |
President/Director/Head Business Group/Unit/Division |
Bristol Myers Squibb (BMS) (Group) |
New Jersey (federal state) |
| Polack, Axel (Joint Polish Investment Fund 201503 General Partner before TVM since 2000 General Partner Life Sciences) |
General Partner (venture partner) |
Joint Polish Investment Fund (JPIF) (Group) |
Netherlands_o |
| Silverman, Bob (Gilde Healthcare 201305– Operational Partner before mtm laboratories 200807– CEO joined mtm 2005) |
Investment Manager |
Gilde Investment (Group) |
Netherlands_o |
| Bates, Kathy L. (Mayo Clinic 201912 Senior Director Lab Services + Partnership Developm + Numares Supersvisory Board) |
President/Director/Head of Research Organisation/Unit |
Mayo Clinic |
Minnesota (federal state) |
| Bauer, Peter (Centogene 201601– COO before Univ Hospital Tübingen Professor) |
Chief Operating Officer (COO) |
Centogene (Group) |
Mecklenburg-Vorpommern (federal state) |
| Bäuerle, Patrick (MPM Capital 201710 Managing Director formerly Micromet) |
Managing Director |
MPM Capital (Group) |
Massachusetts (federal state) |
| Dorton, Katina (AvroBio 201709– CFO before Immatics + Needham & Co + Morgan Stanley + Sullivan & Chromwell) |
Chief Financial Officer (CFO) |
AvroBio (Group) |
Massachusetts (federal state) |
| Feist, Frank (BlueCatBio 201411– CEO + Founder before NobleGen Biosciences + BC + Olympus America + Polytechnos) |
Chief Executive Officer (CEO) |
BlueCatBio (BCB) (Group) |
Massachusetts (federal state) |
| Menichella, Daniel L. (Dan) (Kaleido Biosciences 202010– CEO before CureVac + Bamboo Therapeutics + AGTC + Zyngenia) |
Chief Executive Officer (CEO) |
Kaleido Biosciences Inc. (Nasdaq: KLDO) |
Massachusetts (federal state) |
| Prause, Burkhard (Bruker 200804– President of BEST joined 2002 before MPI Tuebingen) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
Massachusetts (federal state) |
| Angermayer, Christian (Apeiron Investment 202010 Founder formerly Co-founder of Ribopharma) |
Company Founder |
ANGERMAYER Group (Apeiron Investment Group/Presight Ventures) (family of Christian Angermayer) |
Malta_o |
| Schneider, Christian (Vesalius Biocapital 201006 Investment Manager before Polytechnos since 2001 before Centocor) |
Investment Manager |
Vesalius Biocapital (Group) |
Luxembourg (cl=4) |
| Ternes, Frank (Northway 201810– CBO at Biotechpharma UAB before Rentschler + Boehringer Ingelheim) |
Chief Business Officer (CBO) |
Northway (Group) |
Lithuania_o |
| Sadiq, Kashif (DenovAI Biotech 202302– CEO + Co-Founder before EMBL) |
Chief Executive Officer (CEO) |
DenovAI Biotech (IL/DE) |
Israel_o |
| Arbogast, Susanne (Roche 201308 Head Innovation + External Affairs at Roche Diagnostics) |
Business Development Manager / Strategy Manager |
Roche (Group) |
Indiana (federal state) |
| Pfahlert, Volker (LipoFIT GmbH 201001– Managing Director COO before Roche Diagnostics + Dräger Medical) |
Managing Director |
Roche (Group) |
Indiana (federal state) |
| Zabrowski, Dan (Roche 201202– Head Roche Applied Science before Roche Global Head Pharma Partnering) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
Indiana (federal state) |
| Emmerich, Niels (AbbVie 201504– Global Head Search + Evaluation Oncology joined 201110 before Biopheresis + Immatics) |
Business Development Manager / Strategy Manager |
AbbVie (Group) |
Illinois (federal state) |
| Hummel, Berthold (Baker McKenzie 202106 before Dechert) |
Attorney / Lawyer |
Baker McKenzie LLP |
Illinois (federal state) |
| Fagerberg, Jan (Enterome 202103 CMO formerly Micromet 200911 SVP + CMO) |
Chief Medical Officer (CMO) |
Enterome S.A. |
Île-de-France (region) |
| Gauer, Christoph (EliTech Group 202312 CEO before Siemens + Olympus + Advalytix) |
Chief Executive Officer (CEO) |
Elitech (Group) |
Île-de-France (region) |
| Mühlenweg, Bernd (Nanobiotix 2011– Head Business Development before 2001–2011 Head BusDev at Wilex AG) |
Business Development Manager / Strategy Manager |
Nanobiotix (Group) |
Île-de-France (region) |
| Straubinger, Helmut J. (Tricares 201603–2024032 CEO formerly JenaValve 200709 CEO RETIRED 3/24) |
Chief Executive Officer (CEO) |
Tricares (Group) |
Île-de-France (region) |
| Zhukovsky, Eugene (Biomunex 201510– CSO before Affimed + Boehringer Ingelheim Pharmaceuticals + Xencor) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Biomunex Pharmaceuticals SASU |
Île-de-France (region) |
| Bourdon, Christophe (Leo Pharma 202204– CEO before Orphazyme + Amgen + Alexion) |
Managing Director |
Leo Pharma (Group) |
Hovedstaden |
| Jørgensen, John Bagterp (Technical Univ of Denmark 202107 Professor at Dept of Applied Mathematics + Computer Science) |
Professor |
Technical University of Denmark (DTU) |
Hovedstaden |
| Thestrup, Thomas Michael (Sunstone Capital 201509– Associate before Denmark (govt) Consultant Life Science ICD Munich) |
Investment Manager |
Sunstone Life Science (Group) |
Hovedstaden |
| Brosnan, Michael (Fresenius Medical Care 201804 CFO + proposed to MorphoSys Supervisory Board) |
Chief Financial Officer (CFO) |
Fresenius (Group) |
Hessen (Hesse) (federal state) |
| Feling, Nicole (Köhl et Feling 201310 Partner + Bicoll PR) |
Public Relations Manager / Investor Relations Manager |
Innovation Industries (NL) |
Hessen (Hesse) (federal state) |
| Homberg, Peter (Dentons/Salans 201211 Partner Ffm before Raupach & Wollter-Elmendorff + Jones Day + Roche) |
Attorney / Lawyer |
Dentons (Group) |
Hessen (Hesse) (federal state) |
| Netzer, Tilo (PharmaLex 201401– Managing Director/COO joined 201206 before Merck Serono) |
Managing Director |
PharmaLex (Group) |
Hessen (Hesse) (federal state) |
| Oschmann, Stefan (Merck (DE) 201604– CEO before Executive Board Member since 2011 before MSD) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
Hessen (Hesse) (federal state) |
| Reitermann, Michael (Siemens 201306 CEO of Siemens Healthcare Diagnsotics before President Molecular Imaging) |
Chief Executive Officer (CEO) |
Siemens (Group) |
Hessen (Hesse) (federal state) |
| Schüler, Julia (BioMedServices 201101– before BioRegion Rhein-Neckar 200910–201012 Managing Director + E&Y Mannheim) |
consulting (economic) |
Bio.Aspekte – Dr. Julia Schüler |
Hessen (Hesse) (federal state) |
| Bachmann, Thomas (Eppendorf 201508–201911 CEO before Pesident of Bruker BioSpin Group + Tecan CEO LEFT 12/19) |
Chief Executive Officer (CEO) |
Eppendorf (Group) |
Hamburg (federal state) |
| Grättinger, Mira (European ScreeningPort 201011 Vice President before NascaCell Technologies) |
n. a. |
Fraunhofer (Group) |
Hamburg (federal state) |
| Herrenknecht, Kurt (SciArcum 201110– before Proteros + Zukunftsfonds Heilbronn + PerkinElmer + Evotec + Eisai) |
Business Development Manager / Strategy Manager |
SciArcum Biotech Consulting – Dr. Kurt Herrenknecht |
Hamburg (federal state) |
| Jaeger, Axel (Eppendorf 202006– CFO before Wash Tec AG + Carl Zeiss Group) |
Chief Financial Officer (CFO) |
Eppendorf (Group) |
Hamburg (federal state) |
| Ullmann, Dirk (Evotec 202209 Global Head Drug Discovery Services before Proteros Biostructures + Evotec) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Evotec (Group) |
Hamburg (federal state) |
| Glass, Steve (BioMarin Europe 200801– VP + General Manager before Altana) |
Managing Director |
BioMarin (Group) |
Greater London (region) |
| Itin, Christian (Autolus 201603– CEO before Cytos 201211–201601 + Micromet 1999–2012 CEO + Co-founder + Zyomyx Inc) |
Chief Executive Officer (CEO) |
Autolus Therapeutics plc (Nasdaq: AUTL) |
Greater London (region) |
| Hoffmann, Manfred (WBG Pflegeheime 202005 Investor + Spindiag 2019– Investor) |
n. a. |
WBG Pflegeheime (DE, WBG Nursing Homes) |
Germany (state/region unspecified) |
| Pfundner, Hagen (Roche 202405– CEO of Roche Deutschland Holding before CEO of Roche Pharma AG) |
Chief Executive Officer (CEO) |
Roche (Group) |
Germany (state/region unspecified) |
| Mummenbrauer, Torsten (ExeVir Bio 202006– CEO before Velvio Gmbh + Hookipa + MorphoSys + GSK Vaccines) |
Business Development Manager / Strategy Manager |
ExeVir Bio B.V. |
Flanders (Flemish region) |
| Kueppers, Evert (Pevion Biotech 201009– CEO before Pieris AG CEO before IDEA AG Head Business Development) |
Chief Executive Officer (CEO) |
Pevion Biotech AG |
Espace Mittelland (region) |
| Fässler, Christoph (Metrohm 201107 CEO) |
Chief Executive Officer (CEO) |
Metrohm (Group) |
Eastern Switzerland (region) |
| Günther, Rolf H. (Bicycle Therapeutics 201204– CEO before Affimed 2004– CEO + COO before Aventis Behring) |
Chief Executive Officer (CEO) |
Bicycle Therapeutics (Group) |
East of England (region) |
| Kusser, Wolfgang (Automation Partnership 201102– Sales Manager DE+AT+CH before Invitrogen Germany) |
Sales Manager / Marketing Manager |
Sartorius (Group) |
East of England (region) |
| Rausch, Oliver (Storm Therapeutics 201702 VP R&D before Cellzome + UCB Celltech + GSK) |
Research & Development Manager |
Storm Therapeutics Ltd. |
East of England (region) |
| Schottelius, Arndt (Kymab 201806 EVP RnD before MorphoSys 200812–201701 Chief Developm Officer before Genentech) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Sanofi (Group) [since May 2011] |
East of England (region) |
| Appelmann, Karl (Gentium 201111– Country Manager DE+ AT + CH before ViroLogik 201105 Managing Director) |
Regional manager |
Jazz Pharmaceuticals (Group) |
Central Switzerland (region) |
| Asam, Alexander (HBM Partners 201304 Investment Advisor before Kaneas Capital 2006– founder before DVC) |
Investment Manager |
HBM (Group) |
Central Switzerland (region) |
| George, Jeff (Novartis 201404– Divison Head of Alcon before Division Head of Sandoz) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Central Switzerland (region) |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
Region
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
